CLOPIDOGREL

作品数:154被引量:581H指数:15
导出分析报告
相关领域:医药卫生更多>>
相关作者:邹建军邱声强张冰胡正刚王庄更多>>
相关机构:南京医科大学中国药科大学湖州市中心医院太原市中心医院更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家科技支撑计划国家重点基础研究发展计划河北省自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=World Journal of Cardiologyx
条 记 录,以下是1-7
视图:
排序:
Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view
《World Journal of Cardiology》2023年第8期375-394,共20页Maurizio Giuseppe Abrignani Alberto Lombardo Annabella Braschi Nicolo Renda Vincenzo Abrignani 
Aspirin,other antiplatelet agents,and anticoagulant drugs are used across a wide spectrum of cardiovascular and cerebrovascular diseases.A concomitant proton pump inhibitor(PPI)treatment is often prescribed in these p...
关键词:Antithrombotic drugs ANTICOAGULANTS ASPIRIN CLOPIDOGREL Gastrointestinal bleeding Proton pump inhibitors 
P2Y12-ADP receptor antagonists: Days of future and past被引量:4
《World Journal of Cardiology》2016年第5期327-332,共6页Marc Laine Franck Paganelli Laurent Bonello 
Antiplatelet therapy is the cornerstone of the therapeutic arsenal in coronary artery disease.Thanks to a better understanding in physiology,pharmacology and pharmacogenomics huge progress were made in the field of pl...
关键词:CLOPIDOGREL PRASUGREL Ticagrelor Acute coronary syndrome Ticagrelor CANGRELOR 
Clinical evidence of interaction between clopidogrel and proton pump inhibitors被引量:4
《World Journal of Cardiology》2011年第5期153-164,共12页Shoa-Lin Lin Jaw-Wen Chan 
Supported by(in part)The Kaohsiung Veterans General Hospital,Grant No.VGHKS98-034
Clopidogrel is approved for reduction of atherothrombotic events in patients with cardiovascular(CV)and cerebrovascular disease.Dual antiplatelet therapy with aspirin and clopidogrel decreases the risk of major advers...
关键词:ANTIPLATELET therapy ASPIRIN CLOPIDOGREL PROTON PUMP INHIBITOR 
Clinical importance of aspirin and clopidogrel resistance被引量:36
《World Journal of Cardiology》2010年第7期171-186,共16页Gergely Feher Andrea Feher Gabriella Pusch Katalin Koltai Antal Tibold Beata Gasztonyi Elod Papp Laszlo Szapary Gabor Kesmarky Kalman Toth 
Supported by The University of Pecs (PTE AOK KA-34039-16/2009)
Aspirin and clopidogrel are important components of medical therapy for patients with acute coronary syndromes, for those who received coronary artery stents and in the secondary prevention of ischaemic stroke. Despit...
关键词:ASPIRIN CLOPIDOGREL ANTIPLATELET agent ASPIRIN RESISTANCE CLOPIDOGREL RESISTANCE CARDIOVASCULAR outcome PLATELET aggregation 
Alternatives to clopidogrel for acute coronary syndromes:Prasugrel or ticagrelor?被引量:1
《World Journal of Cardiology》2010年第6期131-134,共4页Giuseppe Biondi-Zoccai Marzia Lotrionte Fiorenzo Gaita 
Clopidogrel is a mainstay in the treatment of patients with acute coronary syndromes or those receiving endovascular prostheses.However,its efficacy has been challenged in the recent past by studies suggesting variabl...
关键词:ACUTE CORONARY SYNDROME CLOPIDOGREL PRASUGREL Ticagrelor 
Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration被引量:9
《World Journal of Cardiology》2010年第6期160-162,共3页Yuan-Lin Guo   Jian-Jun Li   Jin-Qing Yuan   Xue-Wen Qin   Xin Zheng   Chao-Wei Mu   Yi-Hong Hua 
Clopidogrel has shown an excellent safety,tolerability and efficacy ever since its marketing.However,here we report a rare case with profound thrombocytopenia following clopidogrel administration previously safely exp...
关键词:CLOPIDOGREL THROMBOCYTOPENIA CORONARY ARTERY disease STENT 
Antithrombotic management of patients on oral anticoagulation undergoing coronary artery stenting被引量:4
《World Journal of Cardiology》2010年第3期64-67,共4页Andrea Rubboli 
Patients on oral anticoagulation(OAC),who are referred for coronary artery stenting account for about 5% of the whole population undergoing percutaneous coronary intervention(PCI).Although relatively small,this patien...
关键词:ANTICOAGULANTS WARFARIN ASPIRIN CLOPIDOGREL STENTS Percutaneous coronary intervention 
检索报告 对象比较 聚类工具 使用帮助 返回顶部